Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02231463
Other study ID # CVL-Position-1
Secondary ID
Status Withdrawn
Phase N/A
First received June 4, 2014
Last updated January 25, 2016
Start date June 2014
Est. completion date December 2015

Study information

Verified date January 2016
Source Universitätsklinikum Köln
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Observational [Patient Registry]

Clinical Trial Summary

In 50 Patients who are undergoing a planned surgical procedure which require a central venous catheter the diameter of the subclavian vein is measured by ultrasound under 6 different conditions.


Description:

In 50 Patients who are undergoing a planned surgical procedure which require a central venous catheter the diameter of the subclavian vein is measured by ultrasound under 6 different conditions. The conditions are

1. neutral positioning, PEEP 0 cm H2O,

2. neutral positioning, PEEP 5cm H2O,

3. neutral positioning, PEEP 10cm H2O,

4. Trendelenburg positioning -20°, PEEP 0 cmH2O,

5. Trendelenburg positioning -20°, PEEP 5 cmH2O,

6. Trendelenburg positioning -20°, PEEP 10 cmH2O After these measurements a central venous catheter is used to measure the central venous pressure.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age >18 years

- cardiosurgery or neurosurgery

- written informed consent

- ECG: inus rhythm

Exclusion Criteria:

- peacemaker

- kontraindications for PEEP

- pulmonary disease

- hemodynamically instable patients

- pregnancy

- pulmonal Hypertension

- ejection fraction < 35%

- severe valvular disease

- tricuspid insufficiency

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
neutral positioning, PEEP 0 cm H2O
neutral positioning, PEEP 0 cm H2O
neutral positioning, PEEP 5cm H2O
neutral positioning, PEEP 5cm H2O
neutral positioning, PEEP 10cm H2O
neutral positioning, PEEP 10cm H2O
Trendelenburg positioning -20°, PEEP 0 cmH2O
Trendelenburg positioning -20°, PEEP 0 cmH2O
Trendelenburg positioning -20°, PEEP 5 cmH2O
Trendelenburg positioning -20°, PEEP 5 cmH2O
Trendelenburg positioning -20°, PEEP 10 cmH2O
Trendelenburg positioning -20°, PEEP 10 cmH2O

Locations

Country Name City State
Germany UK Köln Cologne NRW

Sponsors (1)

Lead Sponsor Collaborator
Universitätsklinikum Köln

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diameter of vein measurement of vein Diameter by ultrasound in a randomized order only 1 day (the day of the measurement); no follow-up is required No
See also
  Status Clinical Trial Phase
Completed NCT02902939 - Myeloid-Derived Supressor Cells in Cardiac Surgery Patients N/A